NS 220

Drug Profile

NS 220

Alternative Names: NS-220; R 1593

Latest Information Update: 24 May 2010

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Nippon Shinyaku
  • Class Antihyperlipidaemics; Dioxanes; Oxazoles; Small molecules
  • Mechanism of Action Peroxisome proliferator-activated receptor alpha agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Atherosclerosis; Lipid metabolism disorders; Type 2 diabetes mellitus

Most Recent Events

  • 24 May 2010 Discontinued - Preclinical for Atherosclerosis in Japan (unspecified route)
  • 24 May 2010 Discontinued - Preclinical for Lipid metabolism disorders in Japan (unspecified route)
  • 24 May 2010 Discontinued - Preclinical for Type-2 diabetes mellitus in Japan (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top